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8S RANDALL ET AL 
medium, i.e., that in which confluent dermal papilla cells had been 
grown for 48 h, was tested for growth-promoting activity on a 
human skin keratinocyte cell line using an MTT assay. Normal 
dermal papilla cell medium stimulated keratinocyte growth signif­
icandy at low concentrations compared to control non-conditioned 
medium but alopecia areata cell medium had no effect. This 
suggests that dermal papilla cells from normal follicles secrete 
soluble mitogenic factors that are not produced by alopecia areata 
cells. This obviously merits further investigation as the absence of 
such mitogenic factors could be involved in the altered keratinocyte 
activity in the alopecia areata hair follicle. 
Overall, there are a number of aspects that implicate the dermal 
papilla in the pathogenesis of alopecia areata. Although it seems 
likely that the dermal papilla plays a key role at an early stage in the 
disease, it is not yet clear whether this is an etiologic role or part of 
the follicle's defense responses to an insult elsewhere in the follicle 
such as the melanocytes or follicular keratinocytes. 
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APOPTOSIS IN IMMUNOLOGIC CYTOTOXICITY 
Apoptosis is an important biologic process involved in mod­
ulation of cell populations during development and differentia­
tion and in elimination of damaged cells to maintain functional 
integrity of many organs [1]. Dysregulation of apoptosis pro­
motes survival of malignant cells. Alteration of apoptosis in the 
immune system is crucial in the development of autoimmunity. 
Apoptosis is also one outcome of immunologic cytotoxicity. Immu­
nologic cytotoxicity is a fundamental mechanism in the immune 
response, producing selective destruction of cellular targets by hu­
moral or cellular effector mechanisms. Necrosis induced by membrane 
damage and triggering of apoptosis are important endpoints of im­
munologic cytotoxicity [2]. Activated cytotoxic T lymphocytes can 
induce apoptosis through binding of a surface ligand to the F AS 
receptor on the target. Apoptosis can also be mediated by cytokines 
released by activated lymphocytes or macrophages such as tumor 
necrosis factor (TNF) and interferon gamma (IFN-y). Cytotoxic 
lymphocytes activated through the T-cell receptor release perforins 
and granzymes that induce target cell death through necrosis or 
apoptosis. Thus, cytotoxic T cells can induce both apoptosis and 
necrosis [2]. Other cytotoxic effectors such as activated macrophage 
and lymphokine-activated killers can also produce combinations of 
necrosis induced by perforins and apoptosis induced by cytokine 
release. 
APOPTOSIS IN THE SKIN: ROLE IN EPIDERMIS AND THE 
HAIR FOLLICLE 
Ultrastructural and biochemical analysis has established that apop­
tosis is seen in normal epidermis and in the matrix of cycling hair 
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follicles [3]. Apoptosis can also be identified in aberrant locations in 
diseases such as lichen planus where basal keratinocyte apoptosis 
has been described. The proto-oncogene Bcl-2 is found in the basal 
keratinocyte layer [4], and may act as an inhibitor of basal kerati­
nocyte apoptosis. Stenn and colleagues have recently demonstrated 
in mouse hair follicles that Bcl-2 expression is maintained in dermal 
papilla cells during catagen and telogen, but that Bcl-2 levels 
decrease in the hair bulb, in the bulge and in the outer root sheath 
during catagen and telogen [5]. The implication is that the dermal 
papilla is protected by Bcl-2 from the induction of apoptosis. 
APOPTOSIS OF DERMAL PAPILLA CELLS IN 
ALOPECIA AREATA 
Degenerative changes in dermal papilla cells in the involved scalp 
of alopecia areata [6] indicate that these cells are an important target 
in this disease. We propose that the peribulbar lymphocytic infil­
trate in AA damages or suppresses the dermal papilla cells leading to 
initiation of catagen and involution of the follicle. One measure of 
immunologic damage to dermal papilla cells would be induction of 
apoptosis by cytokines or by binding to cells surface FAS. 
To test this hypothesis, we first examined the susceptibility of 
cultured dermal papilla cells from normal donors to the induction of 
apoptosis by ionophores, cytokines, or triggering of FAS. As 
indicated in Table I, dermal papilla cells were susceptible to the 
induction of apoptosis by the ionophore beauvericin, but not by any 
of the cytokines or by anti-FAS. For comparison, the keratinocyte 
cell lines HaCaT and KB were susceptible to low-level induction of 
apoptosis by a number of immunologic mediators. Thus cultured 
dermal papilla cells appear to be resistant to the induction of 
apoptosis by immunologic mediators. 
We then examined nine biopsies from alopecia areata patients, 
for morphologic evidence of apoptosis in the dermal papillae as 
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Table I. Apoptosis of Cultured Dermal Papilla Cells and 
Keratinocyte Cell Lines 
Percent Apotosis' 
Trigger of 
Apoptosis Dermal Papilla KB HaCaT 
Control 2 0 7 
IFN-y 2 1 5 
TNF-ll 2 6 6 
TNF-ll plus IFN-y 2 4 23 
IL-l 0 4 9 
Anti-FAS 0 4 9 
IFN-y +.anti-FAS 0 58 16 
Beauvericin 62 52 ND 
"Percent apoptosis determined by Hoechst staining of cell cultures exposed to 
different triggen fur apoptosis for 4 h. ND, not done. 
induced by nuclear Hoechst staining or of DNA nicking as mea­
sured by TUNEL staining. We observed apoptotic cells in the 
dermal papilla with both Hoechst and TUNEL techniques. Staining 
for the anti-apoptotic protein Bcl-2 showed detectable levels of 
Bcl-2 in the dermal papilla of AA patients. 
These studies are preliminary indication that dermal papilla 
damage may be a critical component of alopecia areata, and that 
apoptosis is one endpoint observed. The presence of BcI-2 in the 
same papilla indicates that an apoptosis may be induced in the 
presence of intact anti-apoptotic defenses. 
It must be noted that in hematopoietic and non-hematopoietic 
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tumors, expression of FAS and Bcl-2 are not necessarily predictors 
of induction of or protection against apoptosis, respectively [7]. 
However, it is our experience that in human keratinocytes and 
melanocytes, Bcl-2 expression is an effective if imperfect protection 
against induction of apoptosis. 
We propose that apoptosis is one of the cytotoxic effects seen in 
dermal papillae in alopecia areata as a result of immunologic 
cytotoxicity. Further studies are necessary to determine whether 
cell death or inhibition in the dermal papillae is a central component 
of alopecia areata. 
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T he identity of the primary disease target in alopecia areata remains in doubt. Histologic and ultrastruc­tural evidence of cellular damage and increased expression of class I and class II HLA antigens led to the suggestion that cells undergoing early cortical 
differentiation are the principal focus for immune-mediated attack 
[1]. However, increased HLA expression by hair-matrix keratino­
cytes appears to be a relatively late event and may result from 
cytokine release by infiltrating immune cells. We have previously 
shown that the cytokines interferon-gamma and tumor necrosis 
factor-alpha are insufficient stimuli to induce ill vitro the patterns of 
increased human leukocyte antigen and intercellular adhesion 
molecule-l expression seen in the hair follicle in vivo in alopecia 
areata, suggesting other factors are crucial in d1e pathogeneticsequence 
[2]. Alopecia areatais known to involve disturbance of immune 
function but there is no compelling evidence for a primary autoim­
mune mechanism. To unifY theories on the pathogenesis, we proposed 
a new hypothesis that pro-inflammatory and chemo-attractant cyto­
kine production due to dermal papilla dysfunction leads to hair-matrix 
keratinocyte damage with an inflammatory response and consequent 
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disturbance of hair growth. To investigate dermal papilla function in 
alopecia areata, we studied the ability of cultured dermal papilla cells 
from perilesional sites to promote lymphocyte proliferation in vitm. We 
have also studied indirecdy the role of locally produced antiprolifera­
tive cytokines of the type I interferon family by immunohistochemical 
assessment of the expression of Mx protein, a sensitive marker for 
interferon alpha/beta activity [3]. 
MATERIALS AND METHODS 
Perilesional and non-Iesional scalp biopsies were obtained from alopecia 
areata patients (n = 8); normal control scalp tissue from patients having 
removal of benign tumors/nevi (n = 5). Cnltured cells obtained as 
previously described [4] were used between passages 2 and 4 and cell-free 
supernatants prepared by filtration. Cultured dermal papilla cells from 
normal scalp and non-lesional and perilesional alopecia areata tissues were 
used to produce test supernatants with peripheral blood mononuclear cells 
from both nonnal individuals and patients with active alopecia areata as the 
responder population in a microculture lymphocyte proliferation assay using 
3H-thymidine incorporation to assess proliferation. Interleukin-6 (IL-6) was 
measured by the B9 hybridoma bioassay and an enzyme-linked immunosor­
bent assay technique. Mx protein expression was assessed by avidin-biotin 
immunoperoxidase staining of tissue sections using three monoclonal 
antibodies kindly snpplied by Drs. H. Towbin and M.A. Horisberger, CIBA 
Geigy, Basel, Switzerland. 
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